Literature DB >> 10720608

Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease.

R J Johnson1, K R Tuttle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10720608     DOI： 10.1161/01.hyp.35.3.e10

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  "Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Remi Kuwabara; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Petter Bjornstad; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Minoru Ohno; James O Hill; Miguel A Lanaspa; Richard J Johnson
Journal:  Obesity (Silver Spring)       Date:  2017-09-18       Impact factor: 5.002

3.  Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.

Authors:  M S Lipkowitz; E Leal-Pinto; J Z Rappoport; V Najfeld; R G Abramson
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

5.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

Review 6.  Galectin 9 is the sugar-regulated urate transporter/channel UAT.

Authors:  Michael S Lipkowitz; Edgar Leal-Pinto; B Eleazar Cohen; Ruth G Abramson
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 7.  Uric acid in metabolic syndrome: From an innocent bystander to a central player.

Authors:  Mehmet Kanbay; Thomas Jensen; Yalcin Solak; Myphuong Le; Carlos Roncal-Jimenez; Chris Rivard; Miguel A Lanaspa; Takahiko Nakagawa; Richard J Johnson
Journal:  Eur J Intern Med       Date:  2015-12-15       Impact factor: 4.487

Review 8.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

9.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

10.  Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities.

Authors:  Junnan Wu; Guangtao Lei; Xiao Wang; Yuezhong Tang; Huan Cheng; Guihua Jian; Xianfeng Wu; Niansong Wang
Journal:  Oncotarget       Date:  2017-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.